Activation of group 2 innate lymphoid cells via TL1A/DR3: A Solution to corticosteroid resistance?

Chrysanthi Skevaki, Markus Weckmann

Original languageEnglish
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume202
Issue number8
Pages (from-to)1067-1069
Number of pages3
ISSN1073-449X
DOIs
Publication statusPublished - 15.10.2020

Funding

C.S. is supported by the Universities Giessen and Marburg Lung Center; the German Center for Lung Research (DZL); University Hospital Giessen and Marburg research funding according to article 2, section 3 cooperation agreement; and the Deutsche Forschungsgemeinschaft-funded SFB 1021 (C04), KFO 309 (P10), and SK 317/1-1 (project number 428518790). M.W. is supported by the DZL and the University of Lübeck (E42-2012 and JC01-2016).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

DFG Research Classification Scheme

  • 2.22-20 Pediatric and Adolescent Medicine
  • 2.21-05 Immunology

Cite this